Lodi Valley News.com

Complete News World

Connect SUS now warns that a vaccination certificate will not be issued to those who have taken the vaccine mixture |  the health

Connect SUS now warns that a vaccination certificate will not be issued to those who have taken the vaccine mixture | the health

Connect SUS, the official app of Ministry of Health, to display an alert to make it official that Brazilians who have taken a combination of vaccines cannot be issued a national Covid-19 vaccination certificate.

Users reported a certificate issue issue earlier this month. Problems are mainly reported with those who took the first dose of AstraZeneca, and due to not having the same available fortifying agent, ended up taking a dose of Pfizer, as expected by the government in these cases.

At that time, it was st 1 At the Ministry, which informed that the application is under evaluation by the technical field and that it is waiting for the information to take a position. The folder did not send any explanations. This Friday (15), st 1 He returned to the ministry to find out the prospects for solving the problem.

Understand the certificate and its importance for travel

The “Covid-19 National Certificate of Vaccination” is for the current vaccination campaign against the novel coronavirus epidemic. The document can be viewed directly from the app and has an option to display a QR code and validate via a code.

The document consolidates information about the applications and proves that the citizen took both doses or one dose of Janssen. It can also be issued in English or Spanish.

According to the Ministry of Health, the “National Covid-19 Vaccination Certificate” can be used for international travel.

“Citizens can submit the national certificate whenever they need it, such as international travel, as I informed some countries that recognize the entry document for Brazilians into their territory, as they do not yet have the definition of the international certificate,” the ministry said in August.

Infectious diseases: Pfizer and AstraZeneca interchangeability ‘very safe’